MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 145 filers reported holding MACROGENICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $776,771 | -17.1% | 166,689 | -4.8% | 0.02% | -24.0% |
| Q2 2023 | $936,496 | -8.7% | 175,046 | +22.4% | 0.02% | -10.7% |
| Q1 2023 | $1,025,755 | +544.5% | 143,062 | +503.1% | 0.03% | +460.0% |
| Q4 2022 | $159,161 | -52.5% | 23,720 | -37.6% | 0.01% | -68.8% |
| Q1 2022 | $335,000 | -5.6% | 38,022 | +72.0% | 0.02% | -27.3% |
| Q4 2021 | $355,000 | -25.3% | 22,109 | +17.2% | 0.02% | -29.0% |
| Q3 2020 | $475,000 | -46.1% | 18,867 | -40.3% | 0.03% | -49.2% |
| Q2 2020 | $882,000 | +484.1% | 31,585 | +128.3% | 0.06% | +577.8% |
| Q4 2019 | $151,000 | -74.3% | 13,834 | -57.7% | 0.01% | -78.6% |
| Q1 2019 | $587,000 | -42.8% | 32,673 | -19.9% | 0.04% | -41.7% |
| Q1 2018 | $1,026,000 | +68.8% | 40,776 | +25.8% | 0.07% | +1.4% |
| Q1 2016 | $608,000 | -43.8% | 32,411 | -35.8% | 0.07% | -23.7% |
| Q3 2015 | $1,081,000 | – | 50,500 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,074,316 | $19,316,000 | 17.74% |
| Rhenman & Partners Asset Management AB | 967,186 | $17,390,000 | 2.03% |
| BB BIOTECH AG | 3,400,000 | $61,132,000 | 1.54% |
| Hood River Capital Management LLC | 1,443,196 | $25,949,000 | 1.31% |
| Sofinnova Investments, Inc. | 523,756 | $9,418,000 | 0.91% |
| Prosight Management, LP | 107,560 | $1,934,000 | 0.85% |
| 683 Capital Management, LLC | 484,970 | $8,720,000 | 0.79% |
| Bellevue Group AG | 790,305 | $14,210,000 | 0.78% |
| Opus Point Partners Management, LLC | 30,075 | $541,000 | 0.73% |
| Rubric Capital Management LP | 282,200 | $5,074,000 | 0.47% |